Scott CJ - Search Results

1

USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.

Burrows JF, Kelvin AA, McFarlane C, Burden RE, McGrattan MJ, De la Vega M, Govender U, Quinn DJ, Dib K, Gadina M, Scott CJ, Johnston JA. Burrows JF, et al. Among authors: scott cj. J Biol Chem. 2009 Apr 3;284(14):9587-95. doi: 10.1074/jbc.M807216200. Epub 2009 Feb 2. J Biol Chem. 2009. PMID: 19188362 Free PMC article.

2

CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.

Orr SJ, Morgan NM, Elliott J, Burrows JF, Scott CJ, McVicar DW, Johnston JA. Orr SJ, et al. Among authors: scott cj. Blood. 2007 Feb 1;109(3):1061-8. doi: 10.1182/blood-2006-05-023556. Epub 2006 Sep 28. Blood. 2007. PMID: 17008544 Free article.

3

Detection of cathepsin S cysteine protease in human brain tumour microdialysates in vivo.

Flannery T, McConnell RS, McQuaid S, McGregor G, Mirakhur M, Martin L, Scott C, Burden R, Walker B, McGoohan C, Johnston PG. Flannery T, et al. Br J Neurosurg. 2007 Apr;21(2):204-9. doi: 10.1080/02688690701248190. Br J Neurosurg. 2007. PMID: 17453790 Clinical Trial.

4

Inhibition of cathepsin L-like proteases by cathepsin V propeptide.

Burden RE, Snoddy P, Jefferies CA, Walker B, Scott CJ. Burden RE, et al. Among authors: scott cj. Biol Chem. 2007 May;388(5):541-5. doi: 10.1515/BC.2007.053. Biol Chem. 2007. PMID: 17516850

5

Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles.

Scott CJ, Marouf WM, Quinn DJ, Buick RJ, Orr SJ, Donnelly RF, McCarron PA. Scott CJ, et al. Pharm Res. 2008 Jan;25(1):135-46. doi: 10.1007/s11095-007-9400-7. Epub 2007 Aug 3. Pharm Res. 2008. PMID: 17674157

6

Activity-based selection of a proteolytic species using ribosome display.

Quinn DJ, Cunningham S, Walker B, Scott CJ. Quinn DJ, et al. Among authors: scott cj. Biochem Biophys Res Commun. 2008 May 23;370(1):77-81. doi: 10.1016/j.bbrc.2008.03.013. Epub 2008 Mar 14. Biochem Biophys Res Commun. 2008. PMID: 18343221

7

Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment.

Burden RE, Snoddy P, Buick RJ, Johnston JA, Walker B, Scott CJ. Burden RE, et al. Among authors: scott cj. Mol Cancer Ther. 2008 Mar;7(3):538-47. doi: 10.1158/1535-7163.MCT-07-0528. Mol Cancer Ther. 2008. PMID: 18347141

8

Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.

McCarron PA, Marouf WM, Quinn DJ, Fay F, Burden RE, Olwill SA, Scott CJ. McCarron PA, et al. Among authors: scott cj. Bioconjug Chem. 2008 Aug;19(8):1561-9. doi: 10.1021/bc800057g. Epub 2008 Jul 16. Bioconjug Chem. 2008. PMID: 18627195

9

A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling.

McKeen HD, McAlpine K, Valentine A, Quinn DJ, McClelland K, Byrne C, O'Rourke M, Young S, Scott CJ, McCarthy HO, Hirst DG, Robson T. McKeen HD, et al. Among authors: scott cj. Endocrinology. 2008 Nov;149(11):5724-34. doi: 10.1210/en.2008-0168. Epub 2008 Jul 31. Endocrinology. 2008. PMID: 18669603

10

Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis.

Burden RE, Gormley JA, Jaquin TJ, Small DM, Quinn DJ, Hegarty SM, Ward C, Walker B, Johnston JA, Olwill SA, Scott CJ. Burden RE, et al. Among authors: scott cj. Clin Cancer Res. 2009 Oct 1;15(19):6042-51. doi: 10.1158/1078-0432.CCR-09-1262. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters